700 related articles for article (PubMed ID: 25720716)
1. Omega-3 fatty acids and cardiovascular disease.
Jain AP; Aggarwal KK; Zhang PY
Eur Rev Med Pharmacol Sci; 2015; 19(3):441-5. PubMed ID: 25720716
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids.
Covington MB
Am Fam Physician; 2004 Jul; 70(1):133-40. PubMed ID: 15259529
[TBL] [Abstract][Full Text] [Related]
3. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
5. The utility of omega-3 fatty acids in cardiovascular disease.
Saremi A; Arora R
Am J Ther; 2009; 16(5):421-36. PubMed ID: 19092647
[TBL] [Abstract][Full Text] [Related]
6. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
Holub BJ
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
[TBL] [Abstract][Full Text] [Related]
8. The benefits of ω-3 supplementation depend on adiponectin basal level and adiponectin increase after the supplementation: A randomized clinical trial.
Barbosa MM; Melo AL; Damasceno NR
Nutrition; 2017 Feb; 34():7-13. PubMed ID: 28063515
[TBL] [Abstract][Full Text] [Related]
9. Fish Oil Dilemma: Does It Increase the Risk of Ventricular Arrhythmias and Death? Can Fish Oil Kill You?
Asfaw A; Minhas S; Khouzam AR; Khouzam NR; Khouzam RN
Curr Probl Cardiol; 2021 Mar; 46(3):100718. PubMed ID: 33097299
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
11. What can we expect from omega-3 fatty acids?
Chan EJ; Cho L
Cleve Clin J Med; 2009 Apr; 76(4):245-51. PubMed ID: 19339640
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids from fish oils and cardiovascular disease.
Holub DJ; Holub BJ
Mol Cell Biochem; 2004 Aug; 263(1-2):217-25. PubMed ID: 15524182
[TBL] [Abstract][Full Text] [Related]
13. Do we need 'new' omega-3 polyunsaturated fatty acids formulations?
Cicero AF; Morbini M; Borghi C
Expert Opin Pharmacother; 2015 Feb; 16(3):285-8. PubMed ID: 25474717
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acids and the cardiometabolic syndrome.
Juturu V
J Cardiometab Syndr; 2008; 3(4):244-53. PubMed ID: 19040594
[TBL] [Abstract][Full Text] [Related]
15. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
Bays HE; Tighe AP; Sadovsky R; Davidson MH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
[TBL] [Abstract][Full Text] [Related]
16. History and future of omega-3 fatty acids in cardiovascular disease.
Sperling LS; Nelson JR
Curr Med Res Opin; 2016; 32(2):301-11. PubMed ID: 26566071
[TBL] [Abstract][Full Text] [Related]
17. Dietary omega-3 fatty acid intake and cardiovascular risk.
Psota TL; Gebauer SK; Kris-Etherton P
Am J Cardiol; 2006 Aug; 98(4A):3i-18i. PubMed ID: 16919512
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease prevention and treatment.
von Schacky C
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):193-8. PubMed ID: 19520557
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors.
Mori TA
Food Funct; 2014 Sep; 5(9):2004-19. PubMed ID: 25062404
[TBL] [Abstract][Full Text] [Related]
20. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects.
Kar S
Am J Ther; 2014; 21(1):56-66. PubMed ID: 21975796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
